A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation
Clinical trial NCT05263388 · COMPLETED
Trial details
- NCT number
- NCT05263388
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-15
- Primary completion
- 2024-04-16
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.